Clinical Trials Directory

Trials / Completed

CompletedNCT01163630

Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg

A Phase I, Open-label, Randomized, Single-center, 2-way Crossover Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination Capsule of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
AstraZeneca · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to investigate the effects of food, in comparison to fasting conditions, on the extent and rate of absorption of acetylsalicylic acid (ASA) and esomeprazole.

Conditions

Interventions

TypeNameDescription
DRUGesomeprazole/ASA Fixed Dose Combination (FDC)esomeprazole 20 mg/ASA 81 mg oral capsule

Timeline

Start date
2010-06-01
Primary completion
2010-09-01
Completion
2010-09-01
First posted
2010-07-16
Last updated
2010-12-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01163630. Inclusion in this directory is not an endorsement.